Chi V. Dang

73.0k total citations · 28 hit papers
310 papers, 53.3k citations indexed

About

Chi V. Dang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chi V. Dang has authored 310 papers receiving a total of 53.3k indexed citations (citations by other indexed papers that have themselves been cited), including 223 papers in Molecular Biology, 105 papers in Cancer Research and 46 papers in Oncology. Recurrent topics in Chi V. Dang's work include Cancer, Hypoxia, and Metabolism (87 papers), Ubiquitin and proteasome pathways (39 papers) and Genomics and Chromatin Dynamics (31 papers). Chi V. Dang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (87 papers), Ubiquitin and proteasome pathways (39 papers) and Genomics and Chromatin Dynamics (31 papers). Chi V. Dang collaborates with scholars based in United States, China and Taiwan. Chi V. Dang's co-authors include Jung‐whan Kim, Gregg L. Semenza, Karen Zeller, Zachary E. Stine, Ping Gao, Brian J. Altman, Irina Tchernyshyov, Willem H. Koppenol, Patricia L. Bounds and Kathryn A. O’Donnell and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Chi V. Dang

298 papers receiving 52.5k citations

Hit Papers

HIF-1-mediated expression of pyruvate dehydrogenase kinas... 1997 2026 2006 2016 2006 2011 2012 2005 2009 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
    2006 3.0k citations Gregg L. Semenza, Chi V. Dang et al. profile →
  2. Otto Warburg's contributions to current concepts of cancer metabolism
    2011 2.6k citations Chi V. Dang et al. profile →
  3. MYC on the Path to Cancer
    2012 2.5k citations Chi V. Dang profile →
  4. c-Myc-regulated microRNAs modulate E2F1 expression
    2005 2.1k citations Chi V. Dang et al. profile →
  5. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
    2009 1.7k citations Ping Gao, Angelo M. De Marzo et al. profile →
  6. From Krebs to clinic: glutamine metabolism to cancer therapy
    2016 1.6k citations Brian J. Altman, Zachary E. Stine et al. profile →
  7. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
    1999 1.4k citations Chi V. Dang Molecular and Cellular Biology profile →
  8. Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
    2011 1.3k citations Gregg L. Semenza, Chi V. Dang et al. profile →
  9. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
    2010 1.2k citations Anne Le, Charles R. Cooper et al. Proceedings of the National Academy of Sciences profile →
  10. Widespread microRNA repression by Myc contributes to tumorigenesis
    2007 1.1k citations Chi V. Dang et al. profile →
  11. Cancer's Molecular Sweet Tooth and the Warburg Effect
    2006 984 citations Chi V. Dang et al. Cancer Research profile →
  12. HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells
    2007 967 citations Chi V. Dang, Gregg L. Semenza et al. profile →
  13. The c-Myc target gene network
    2006 932 citations Chi V. Dang et al. profile →
  14. MYC, Metabolism, and Cancer
    2015 929 citations Zachary E. Stine, Zandra E. Walton et al. Cancer Discovery profile →
  15. Oncogenic alterations of metabolism
    1999 891 citations Chi V. Dang, Gregg L. Semenza profile →
  16. Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
    2012 886 citations Anne Le, Arvin M. Gouw et al. profile →
  17. c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
    1997 877 citations Christine Dolde, Brian C. Lewis et al. Proceedings of the National Academy of Sciences profile →
  18. Links between metabolism and cancer
    2012 787 citations Chi V. Dang profile →
  19. Targeting cancer metabolism in the era of precision oncology
    2021 750 citations Zachary E. Stine, Chi V. Dang et al. profile →
  20. HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity
    2007 724 citations Ping Gao, Chi V. Dang et al. profile →
  21. MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
    2009 712 citations Chi V. Dang, Anne Le et al. Clinical Cancer Research profile →
  22. Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
    2000 702 citations Qing Li, Chi V. Dang et al. Journal of Biological Chemistry profile →
  23. Drugging the 'undruggable' cancer targets
    2017 636 citations Chi V. Dang et al. profile →
  24. Multifaceted roles of glycolytic enzymes
    2005 538 citations Chi V. Dang et al. profile →
  25. Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
    2007 523 citations Ping Gao, Gregg L. Semenza et al. Molecular and Cellular Biology profile →
  26. Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
    2008 520 citations Ping Gao, Chi V. Dang et al. Proceedings of the National Academy of Sciences profile →
  27. HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
    2007 430 citations Ping Gao, Ramani Dinavahi et al. profile →
  28. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
    2022 205 citations Gauri Mirji, Sajad A. Bhat et al. Science Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi V. Dang United States 100 38.9k 24.2k 9.5k 5.2k 3.3k 310 53.3k
Matthew G. Vander Heiden United States 91 37.2k 1.0× 26.0k 1.1× 7.3k 0.8× 5.5k 1.1× 3.5k 1.0× 225 54.5k
Amato J. Giaccia United States 103 23.1k 0.6× 17.4k 0.7× 10.8k 1.1× 4.6k 0.9× 4.2k 1.2× 350 40.3k
M. Celeste Simon United States 105 26.3k 0.7× 21.1k 0.9× 7.1k 0.8× 7.2k 1.4× 4.5k 1.3× 262 47.7k
William G. Kaelin United States 117 35.6k 0.9× 22.6k 0.9× 14.8k 1.6× 3.2k 0.6× 6.0k 1.8× 246 50.2k
Jacques Pouysségur France 113 29.0k 0.7× 12.3k 0.5× 6.1k 0.6× 3.7k 0.7× 2.4k 0.7× 369 42.1k
Ralph J. DeBerardinis United States 81 28.3k 0.7× 19.6k 0.8× 5.2k 0.5× 4.2k 0.8× 3.0k 0.9× 233 42.6k
Richard G. Pestell United States 124 33.3k 0.9× 13.5k 0.6× 15.2k 1.6× 4.7k 0.9× 3.7k 1.1× 465 49.9k
Pier Paolo Pandolfi United States 139 61.9k 1.6× 22.9k 0.9× 13.1k 1.4× 10.6k 2.0× 5.0k 1.5× 449 80.3k
Scott W. Lowe United States 123 50.1k 1.3× 16.9k 0.7× 23.0k 2.4× 8.5k 1.6× 3.6k 1.1× 325 69.6k
Karen H. Vousden United Kingdom 105 34.6k 0.9× 12.3k 0.5× 24.4k 2.6× 3.8k 0.7× 2.4k 0.7× 240 49.2k

Countries citing papers authored by Chi V. Dang

Since Specialization
Citations

This map shows the geographic impact of Chi V. Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi V. Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi V. Dang more than expected).

Fields of papers citing papers by Chi V. Dang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi V. Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi V. Dang. The network helps show where Chi V. Dang may publish in the future.

Co-authorship network of co-authors of Chi V. Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi V. Dang. A scholar is included among the top collaborators of Chi V. Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi V. Dang. Chi V. Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Supplee, Julianna, Hayley C. Affronti, Rebekah Brooks, et al.. (2024). ACLY alternative splicing correlates with cancer phenotypes. Journal of Biological Chemistry. 300(7). 107418–107418. 3 indexed citations
2.
Dang, Chi V., et al.. (2024). The Warburg Effect Revisited through Blood and Electron Flow. Cancer Research. 84(13). 2046–2048. 5 indexed citations
3.
Anderson, Kenneth C., Lewis C. Cantley, Riccardo Dalla‐Favera, et al.. (2022). The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Cancer Discovery. 12(11). 2475–2481.
4.
Shao, Hongguang, Patricia Brafford, Zachary E. Stine, et al.. (2022). Na+/H+-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells. Cancer Research Communications. 2(8). 842–856. 1 indexed citations
5.
Sela, Yogev, Jinyang Li, Robert J. Norgard, et al.. (2022). Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer. Cancer Research. 82(10). 1890–1908. 12 indexed citations
6.
Mirji, Gauri, Sajad A. Bhat, Mohamed El Sayed, et al.. (2022). The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Science Immunology. 7(75). eabn0704–eabn0704. 205 indexed citations breakdown →
7.
Walton, Zandra E., Brian J. Altman, Rebekah Brooks, & Chi V. Dang. (2017). Circadian Clock's Cancer Connections. 2(1). 133–153. 11 indexed citations
8.
Rajeshkumar, N.V., Shinichi Yabuuchi, Shweta Pai, et al.. (2017). Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. Clinical Cancer Research. 23(18). 5639–5647. 74 indexed citations
9.
Hu, Zhongyi, Lingegowda S. Mangala, Zachary E. Stine, et al.. (2017). MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels. Cancer Research. 78(1). 64–74. 91 indexed citations
10.
Rajeshkumar, N.V., Prasanta Dutta, Shinichi Yabuuchi, et al.. (2015). Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. Cancer Research. 75(16). 3355–3364. 119 indexed citations
11.
Korangath, Preethi, Wei Wen Teo, Helen Sadik, et al.. (2015). Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate. Clinical Cancer Research. 21(14). 3263–3273. 133 indexed citations
12.
Ji, Zhicheng, Steven A. Vokes, Chi V. Dang, & Hongkai Ji. (2015). Turning publicly available gene expression data into discoveries using gene set context analysis. Nucleic Acids Research. 44(1). e8–e8. 18 indexed citations
13.
Dang, Chi V. & Robert N. Eisenman. (2014). Myc and the pathway to cancer : a subject collection from Cold Spring Harbor perspectives in medicine. 3 indexed citations
14.
Seltzer, Meghan J., Bryson D. Bennett, Avadhut D. Joshi, et al.. (2010). Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1. Cancer Research. 70(22). 8981–8987. 410 indexed citations
15.
Le, Anne, Charles R. Cooper, Arvin M. Gouw, et al.. (2010). Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proceedings of the National Academy of Sciences. 107(5). 2037–2042. 1169 indexed citations breakdown →
16.
Ye, Zhaohui, Huichun Zhan, Prashant Mali, et al.. (2009). Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 114(27). 5473–5480. 276 indexed citations
17.
Eberhart, Charles G., John Kratz, Yunyue Wang, et al.. (2004). Histopathological and Molecular Prognostic Markers in Medulloblastoma. Journal of Neuropathology & Experimental Neurology. 63(5). 441–449. 165 indexed citations
18.
Pangilinan, Faith, et al.. (1997). Mammalian BUB1 Protein Kinases: Map Positions andin VivoExpression. Genomics. 46(3). 379–388. 32 indexed citations
19.
Lee, L A, Christine Dolde, J. Barrett, Chia‐Shan Wu, & Chi V. Dang. (1996). A link between c-Myc-mediated transcriptional repression and neoplastic transformation.. Journal of Clinical Investigation. 97(7). 1687–1695. 59 indexed citations
20.
Dang, Chi V., J. Barrett, Manuel Villa‐Garcia, et al.. (1991). Intracellular Leucine Zipper Interactions Suggest c-Myc Hetero-Oligomerization. Molecular and Cellular Biology. 11(2). 954–962. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew G. Vander Heiden Breakdown of academic impact, for papers by Amato J. Giaccia Breakdown of academic impact, for papers by M. Celeste Simon Breakdown of academic impact, for papers by William G. Kaelin Breakdown of academic impact, for papers by Jacques Pouysségur Breakdown of academic impact, for papers by Ralph J. DeBerardinis Breakdown of academic impact, for papers by Richard G. Pestell Breakdown of academic impact, for papers by Pier Paolo Pandolfi Breakdown of academic impact, for papers by Scott W. Lowe Breakdown of academic impact, for papers by Karen H. Vousden
Rankless by CCL
2026